Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹4,760Cr
Rev Gr TTM
Revenue Growth TTM
15.73%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

DHANUKA
VS
| Quarter | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|
|
Growth YoY Revenue Growth YoY% | 8.0 | 23.7 | 10.2 | 16.6 | -6.0 | 13.8 | 2.5 | -0.8 | 33.7 | 5.9 | 10.4 | 20.0 |
| 341 | 445 | 342 | 293 | 325 | 476 | 341 | 288 | 422 | 495 | 370 | 332 |
Operating Profit Operating ProfitCr |
| 13.1 | 18.0 | 13.2 | 21.0 | 11.8 | 22.9 | 15.4 | 21.8 | 14.5 | 24.4 | 17.0 | 24.8 |
Other Income Other IncomeCr | 17 | 6 | 8 | 15 | 7 | 6 | 7 | 15 | 7 | 11 | 7 | 11 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Depreciation DepreciationCr | 4 | 4 | 4 | 5 | 5 | 10 | 13 | 13 | 12 | 13 | 13 | 17 |
| 64 | 98 | 54 | 87 | 45 | 137 | 56 | 82 | 66 | 157 | 68 | 102 |
| 15 | 25 | 8 | 21 | 12 | 35 | 10 | 22 | 17 | 39 | 13 | 26 |
|
Growth YoY PAT Growth YoY% | 1.1 | 15.2 | 8.3 | 20.0 | -32.9 | 39.4 | -1.5 | -9.6 | 48.5 | 15.5 | 21.3 | 27.9 |
| 12.5 | 13.4 | 11.7 | 17.6 | 8.9 | 16.5 | 11.3 | 16.0 | 9.9 | 18.0 | 12.4 | 17.1 |
| 10.5 | 15.7 | 9.9 | 14.2 | 7.2 | 22.3 | 9.9 | 12.9 | 10.7 | 25.8 | 12.3 | 16.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
|
| | 5.6 | 6.6 | 9.0 | 4.5 | 11.4 | 23.9 | 6.5 | 15.1 | 3.4 | 15.7 |
| 653 | 689 | 713 | 797 | 860 | 947 | 1,118 | 1,214 | 1,422 | 1,431 | 1,619 |
Operating Profit Operating ProfitCr |
| 16.8 | 16.9 | 19.2 | 17.3 | 14.5 | 15.5 | 19.4 | 17.8 | 16.4 | 18.6 | 20.5 |
Other Income Other IncomeCr | 6 | 13 | 18 | 16 | 21 | 25 | 34 | 34 | 45 | 35 | 36 |
Interest Expense Interest ExpenseCr | 3 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 5 |
Depreciation DepreciationCr | 6 | 6 | 15 | 14 | 12 | 16 | 15 | 16 | 18 | 41 | 55 |
| 129 | 145 | 172 | 167 | 154 | 181 | 285 | 278 | 303 | 319 | 392 |
| 23 | 38 | 50 | 41 | 41 | 39 | 74 | 69 | 69 | 80 | 95 |
|
| | 1.2 | 13.6 | 3.5 | -10.8 | 25.6 | 49.0 | -0.8 | 11.8 | 2.4 | 24.2 |
| 13.5 | 12.9 | 13.8 | 13.1 | 11.2 | 12.6 | 15.2 | 14.1 | 13.7 | 13.6 | 14.6 |
| 25.9 | 41.9 | 24.4 | 25.7 | 23.0 | 29.7 | 44.6 | 44.9 | 50.4 | 52.5 | 65.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 3 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 9 |
| 402 | 470 | 512 | 624 | 633 | 698 | 787 | 951 | 1,052 | 1,247 | 1,394 |
Current Liabilities Current LiabilitiesCr | 161 | 144 | 148 | 151 | 163 | 198 | 276 | 304 | 298 | 278 | 349 |
Non Current Liabilities Non Current LiabilitiesCr | 21 | 32 | 46 | 39 | 30 | 27 | 59 | 47 | 46 | 45 | 49 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 449 | 450 | 503 | 577 | 594 | 666 | 858 | 955 | 896 | 1,026 | 1,149 |
Non Current Assets Non Current AssetsCr | 145 | 207 | 211 | 245 | 241 | 266 | 273 | 358 | 509 | 553 | 652 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 110 | 140 | 63 | 138 | 13 | 162 | 231 | 104 | 136 | 134 | 263 |
Investing Cash Flow Investing Cash FlowCr | -70 | -66 | 20 | -111 | 63 | -44 | -127 | -43 | 3 | -81 | -143 |
Financing Cash Flow Financing Cash FlowCr | -38 | -76 | -81 | -20 | -87 | -93 | -129 | -61 | -137 | -57 | -120 |
|
Free Cash Flow Free Cash FlowCr | 85 | 113 | 44 | 131 | 9 | 152 | 219 | 46 | 36 | 46 | 74 |
| 103.6 | 130.2 | 51.8 | 109.1 | 11.8 | 114.7 | 109.7 | 49.9 | 58.3 | 56.2 | 88.5 |
CFO To EBITDA CFO To EBITDA% | 83.5 | 99.9 | 37.2 | 82.9 | 9.1 | 93.5 | 85.9 | 39.6 | 48.9 | 41.1 | 63.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 3,373 | 2,925 | 3,913 | 2,715 | 1,869 | 1,540 | 3,213 | 3,339 | 2,786 | 4,659 | 5,890 |
Price To Earnings Price To Earnings | 9.0 | 29.1 | 32.1 | 21.5 | 16.6 | 10.9 | 15.3 | 16.0 | 11.9 | 19.5 | 19.6 |
Price To Sales Price To Sales | 4.3 | 3.5 | 4.4 | 2.8 | 1.9 | 1.4 | 2.3 | 2.3 | 1.6 | 2.6 | 2.9 |
Price To Book Price To Book | 2.3 | 6.1 | 7.5 | 4.3 | 2.9 | 2.2 | 4.0 | 3.5 | 2.6 | 3.7 | 4.2 |
| 25.7 | 21.0 | 23.1 | 16.3 | 12.9 | 8.8 | 12.1 | 12.8 | 10.1 | 14.3 | 14.3 |
Profitability Ratios Profitability Ratios |
| 37.3 | 39.0 | 43.5 | 41.6 | 38.7 | 36.5 | 37.8 | 36.5 | 34.4 | 39.0 | 40.1 |
| 16.8 | 16.9 | 19.2 | 17.3 | 14.5 | 15.5 | 19.4 | 17.8 | 16.4 | 18.6 | 20.5 |
| 13.5 | 12.9 | 13.8 | 13.1 | 11.2 | 12.6 | 15.2 | 14.1 | 13.7 | 13.6 | 14.6 |
| 31.3 | 30.0 | 32.6 | 26.3 | 23.3 | 25.4 | 34.0 | 28.3 | 27.9 | 25.1 | 26.9 |
| 26.2 | 22.3 | 23.4 | 19.9 | 17.5 | 20.0 | 26.4 | 21.8 | 22.0 | 19.0 | 21.2 |
| 17.9 | 16.3 | 17.1 | 15.3 | 13.5 | 15.2 | 18.6 | 15.9 | 16.6 | 15.1 | 16.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Company Overview**
Dhanuka Agritech Ltd is one of India’s leading agrochemical companies, focused on the manufacturing, marketing, and innovation of **branded formulated crop protection products**, including herbicides, insecticides, fungicides, plant growth regulators, and biologicals. The company operates with a **pan-India presence**, serving **over 10 million farmers** through a vast distribution network and strategic global partnerships. Listed on both the BSE and NSE, it has emerged as a key player in the domestic agrochemical space, with a strategic shift toward **global expansion** and **technology-driven agriculture** in recent years.
---
### **Key Highlights (Recent Developments as of Aug 2025)**
#### **1. Strategic Expansion & Global Ambitions**
- **Acquisition of Global Rights from Bayer AG:**
Dhanuka acquired global manufacturing and sales rights to two high-potential fungicide molecules – **Iprovalicarb** and **Triadimenol** – along with the **Melody brand** and sub-brands. This allows Dhanuka to operate in **over 20 countries** across Latin America, Europe, Asia, Africa, and the Middle East, marking a major strategic pivot into international markets.
- **Dahej Plant as Export Hub:**
The Dahej chemical synthesis plant in Gujarat has commenced **commercial production of Bifenthrin Technical**, with plans to shift manufacturing of at least one acquired Bayer product to this facility. This backward integration supports **cost efficiency**, **global supply capabilities**, and **contract manufacturing (CRAMS)** opportunities.
- **Export Division & Registrations:**
Dhanuka has initiated regulatory registrations in **Brazil, the USA**, and other key markets. The company expects **significant export growth** beginning FY 2025–26, building on the strong foundation of existing registrations under the acquired Bayer portfolio.
#### **2. Innovation & New Product Launches**
- **Dinkar Herbicide Launch:**
A new paddy herbicide, **Dinkar**, developed through collaboration with **Hokko Chemical Japan**, was launched in Q1 FY25–26. It has received **strong farmer response in South India**, with launch events held in **Tirupati, Hyderabad, and Mahabalipuram**.
- **Future Launch Pipeline:**
The company plans to launch **8 new products** over the next two years, primarily in the **margin-accretive Section 9(3)** category. This includes a **new herbicide for transplanted rice** to combat weed resistance.
- **Recent Key Launches (FY24–25):**
- **Purge (Fomesafen + Quizalofop-ethyl)** – Pre-emergence herbicide for soybean and groundnut (in collaboration with Nissan Chemical).
- **LaNevo (Fluxametamide + Bifenthrin)** – Broad-spectrum insecticide for sucking and chewing pests; now among the **Top 10 products** by sales.
- **MYCORe Super** – Premium **Arbuscular Mycorrhizal Fungi (AMF)** biofertilizer for enhanced root development and yield.
- **Tizom, Roxa, Mesotrax, Defend, Semacia** – High-technology agrochemicals in herbicide and insecticide segments.
#### **3. Manufacturing & R&D Infrastructure**
- **Four Manufacturing Units:**
Located in **Sanand, Dahej (Gujarat), Udhampur (J&K), and Keshwana (Rajasthan)**. Dahej is dedicated to **technical manufacturing** (e.g., Bifenthrin, Lambda Cyhalothrin).
- **Dahej Chemical Synthesis Plant:**
Operational since **FY 2023–24**, supported by a **fully equipped R&D lab** with **30 chemists** focused on process innovation and chemical synthesis R&D.
- **NABL-Accredited R&D Labs:**
Two accredited laboratories at Dahej and Sanand. Additional R&D centers include the **Dhanuka Agritech Research & Technology (DART) Center in Palwal, Haryana**, which supports product testing, crop trials, and farmer engagement.
- **Focus Areas:**
- Eco-friendly molecules, novel formulations, and bio-based inputs
- Shelf-life extension, label expansions, and AI-driven crop modeling
- **Digital R&D**: Use of artificial intelligence and data analytics for precision agriculture
#### **4. Distribution & Market Reach**
- **Unparalleled Pan-India Network:**
- **41 Warehouses**
- **6,500+ Distributors**
- **80,000+ Retailers**
Serves **over 10 million farmers** across all agro-climatic zones.
- **Strong Techno-Commercial Team:**
Supported by **over 1,000 trained field staff** responsible for farmer education, product demonstrations, and on-ground support.
- **Digital & Direct Engagement:**
- Over **200,000 YouTube subscribers** – **highest social media penetration** in the Indian agrochemical sector
- Farmer webinars, **Kisan Chaupals**, and WhatsApp-based advisory via **Dhani AI chatbot**
- Partnerships with **AgroStar, Gramophone, Plant It**, and other digital agristacks
#### **5. Strategic Collaborations & Technology Adoption**
- **Global Partnerships:**
Active technical collaborations with **10 leading global agrochemical firms**, including:
- **Nissan Chemical (Japan)** – Sempra, Purge, LaNevo
- **Hokko Chemical (Japan)** – Zanet, Dinkar
- **Corteva, FMC, Syngenta, Mitsui Chemicals, Bayer AG**
- **Biologicals & Sustainable Agriculture:**
- Re-launched **Biologiq** portfolio: includes **Whiteaxe, Nemataxe, Downil, Sporenil, Myconxt, Omninxt**
- Focus on **integrated Pest & Nutrition Management (IPNM)** with **4R principles** (Resistance, Residue, Resurgence, Soil Rejuvenation)
- Strategic intent to expand biologicals segment, currently <5% of ag input market but growing at 18–20% CAGR
- **Precision Agriculture & Digital Tools:**
- Partnerships with drone manufacturer **IoTechWorld Avigation** (invested Rs. 20 crores)
- Uses **drones for product application** and farmer education
- Investments in **digital dealer platforms, supply chain analytics, and intelligent forecasting**
#### **6. Business & Financial Performance**
- **Revenue Milestone:**
- Achieved **₹2,035 crores revenue in FY 2024–25**, crossing the **₹2,000 crore threshold**.
- **Herbicides** emerged as the largest contributor (**50% of sales**) in Q1 FY25–26, followed by insecticides (23%), fungicides (11%), and others (16%).
- **Geographic Sales Mix (Q1 FY25–26):**
- **West India**: 41%
- **North India**: 31%
- **South India**: 19%
- **East India**: 9%
- **“Others” Segment Growth:**
Includes **technical chemicals, PGRs, and traded brands** (e.g., **TORNADO, Dabooch, Nabood, Largo**), showing **double-digit growth**.
- **Royalty Income:**
Generated **₹13 crores** in FY24–25 from two products acquired from Bayer.
- **Export Potential:**
TAM for the two Bayer-acquired molecules estimated at **$100 million globally**; Dhanuka expects **₹110 crores revenue** from these products in FY25–26.
#### **7. Crop-Centric Focus & Portfolio**
- **Product Portfolio:**
- **~90 distinct products**, backed by **300+ regulatory registrations**
- Revenue mix: ~1/3 from **partnerships**, 1/3 from **generics**, 1/3 from **specialty products**
- Targeting increase in **partnership-derived revenue to 33–36%**
- **Top Performers:**
- **Sempra** (10-year collaboration with Nissan) – ₹50 crores revenue, 25 MT volume
- **Targa Super** – 25 years of Japan collaboration
- **Decide, Lustre, Conika, Vitavax, Godiwa Super**, etc.
#### **8. Sustainability & Farmer Engagement**
- **Farmer-Centric Outreach:**
- Conducts **Kisan Chaupals** (60+ events, 10,000+ farmers engaged)
- Runs live webinars and collaborates with **Krishi Vigyan Kendras (KVKs), ICAR**, and **State Agricultural Universities**
- First agrochemical company to partner with **MANAGE** under PPP for **Diploma in Agricultural Extension Services (DAESI)**
- **R&D with Public Institutions:**
MoUs with **ICAR, ANGRAU, MPKV, SKRAU**, and others for joint research and capacity building.
- **Climate-Resilient Farming:**
Invests in **low-residue, eco-friendly formulations**, and **digital ag** tools to support sustainable productivity.
#### **9. Future Outlook (FY2025–26 & Beyond)**
- **Growth Drivers:**
- Strong **9(3) and 9(4) product pipeline**
- **Monsoon performance** remains a key factor, with FY25–26 benefiting from **La Niña-induced favorable rainfall**
- **Global expansion** through Bayer portfolio and Dahej-manufactured exports
- **Strategic Goals:**
- Scale **Bayer-acquired molecules** to international markets
- Transition more **active ingredients and formulations** to **in-house manufacturing**
- Expand **digital adoption, CRAMS services, and bio-inputs**
- **Long-Term Vision:**
To position Dhanuka as a **global integrated crop solutions provider** – combining **chemistry, biology, and digital tools** to drive farm income, food security, and environmental sustainability.
---